Impact of Switching From Darbepoetin Alfa to Epoetin Beta Pegol on Iron Utilization and Blood Pressure in Peritoneal Dialysis Patients-Reference-Cited by-同舟云学术

Impact of Switching From Darbepoetin Alfa to Epoetin Beta Pegol on Iron Utilization and Blood Pressure in Peritoneal Dialysis Patients

Published:2015-05-05 Issue:5 Volume:19 Page:450-456
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Washida Naoki¹,Inoue Shuji²,Kasai Takahiro¹,Shinozuka Keisuke¹,Hosoya Koji³,Morimoto Kohkichi¹,Wakino Shu¹,Hayashi Koichi¹,Itoh Hiroshi¹

Affiliation:

1. Department of Endocrinology, Metabolism and Nephrology; Keio University School of Medicine; Tokyo Japan

2. Department of Nephrology; Saitama Medical Center; Saitama Japan

3. Department of Nephrology; Saiseikai Central Hospital; Tokyo Japan

Publisher

Wiley

Subject

Nephrology,Hematology

Reference30 articles.

1. Latest strategy in renal anemia management in peritoneal dialysis patients;Lo;Perit Dial Int,2008

2. Intravenous methoxy polyethylene glycol-epoetin beta for heamoglobin control in patients with chronic kidney disease who are on dialysis: a randomized non-inferiority trial (MAXIMA);Levin;Lancet,2007

3. Maintenance treatment of renal anaemia in heamodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial;Carrera;Nephrol Dial Transplant,2010

4. Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to Canadian dialysis centres;Jordan;Can J Hosp Pharm,2012

5. An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: the EXTEND study;Galle;Nephrol Dial Transplant,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron deficiency and supplementation in heart failure;Nature Reviews Cardiology;2024-02-07

2. Selenium Associates With Response to Erythropoiesis-Stimulating Agents in Hemodialysis Patients;Kidney International Reports;2022-07

3. Plasma erythropoietin level and heart failure in patients undergoing peritoneal dialysis: a cross-sectional study;Renal Replacement Therapy;2021-01-21

4. Shortened red blood cell age in patients with end-stage renal disease who were receiving haemodialysis: a cross-sectional study;BMC Nephrology;2020-09-29

5. Efficacy and Long-Term Safety of C.E.R.A. Maintenance in Pediatric Hemodialysis Patients with Anemia of CKD;Clinical Journal of the American Society of Nephrology;2017-11-02